Cargando…
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols
BACKGROUND: There are limited research and literature on the trial management challenges encountered in running adaptive platform trials. This trial design allows both (1) the seamless addition of new research comparisons when compelling clinical and scientific research questions emerge, and (2) ear...
Autores principales: | Schiavone, Francesca, Bathia, Riya, Letchemanan, Krishna, Masters, Lindsey, Amos, Claire, Bara, Anna, Brown, Louise, Gilson, Clare, Pugh, Cheryl, Atako, Nafisah, Hudson, Fleur, Parmar, Mahesh, Langley, Ruth, Kaplan, Richard S., Parker, Chris, Attard, Gert, Clarke, Noel W., Gillessen, Silke, James, Nicholas D., Maughan, Tim, Sydes, Matthew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540525/ https://www.ncbi.nlm.nih.gov/pubmed/31138317 http://dx.doi.org/10.1186/s13063-019-3216-8 |
Ejemplares similares
-
Mind the gap? The platform trial as a working environment
por: Morrell, Liz, et al.
Publicado: (2019) -
Changing platforms without stopping the train: experiences of data management and data management systems when adapting platform protocols by adding and closing comparisons
por: Hague, Dominic, et al.
Publicado: (2019) -
Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform
por: Gilson, C., et al.
Publicado: (2017) -
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
por: Attard, Gerhardt, et al.
Publicado: (2022) -
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
por: Love, Sharon B., et al.
Publicado: (2022)